Form 4 for BBIO BridgeBio Pharma, Inc.
Accepted 2026-03-20 00:00:00 ET · period of report 2026-03-18 · accession 0001470831-26-000302 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-03-20 | 2026-03-18 | BBIO | Apuli Maricel | CAO | A - Grant | $0.00 | +14.2K | 136.1K | +12% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-03-18 | A | A | 14,170 | $0.00 | 136,115 | D | — | — | (F2) Each RSU represents a contingent right to receive one share of the Issuer's Common Stock. |